Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell therapy: identification of novel therapeutic vulnerabilities
2021/43/O/NZ5/02693
Keywords
Descriptors
- NZ5_007: Leczenie chorób człowieka
- NZ2_002: Genomika, transkryptomika i epigenomika
- NZ2_007: Bioinformatyka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Hematologii i Transfuzjologii
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM BIS 3 – announced on 2021-09-15
- Amount awarded
- 686 800 PLN
- Project start date
- 2022-10-01
- Project end date
- 2026-09-30
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.